Evaluation of the clinical outcomes of Benidipine initiated by physician's preference in patients with hypertension and/or angina pectoris (chronic coronary syndrome) presenting to cardiology outpatient clinics in Turkey.
* Benidipine is a dihydropyridine calcium channel blocker used in the treatment of hypertension and angina pectoris. There are currently no large-scale observational studies in these patient groups in Turkey. * There is no record of benidipine in clinicaltrials.gov, which is an important database especially for the registration of drug and interventional studies. * Therefore, it will be extremely important to include this study in clinicaltrials.gov and to evaluate the clinical efficacy of Bendipine in patients with hypertensive and/or angina pectoris in 7 geographical regions of Turkey.
Study Type
OBSERVATIONAL
Enrollment
800
The safety and efficacy of a dihydropyridine calcium channel blocker for the treatment of high blood pressure and/or angina pectoris
Antalya Kepez State Hospital
Antalya, Turkey (Türkiye)
The Percentage of Patients Achieving Target Sitting Blood Pressure of Less Than 130/85
Time frame: 3 months
Change in angina symptom severity as measured by the Seattle Angina Questionnaire score from baseline to the end of study
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.